Medication production line
Media playback is unsupported on your device
Video

Genzyme in hostile takover bid by Sanofi-Aventis

French drugmaker Sanofi-Aventis has begun a hostile takeover of Massachusetts-based Genzyme.

The offer values the US biotechnology firm at $18.5bn.

It is the biggest hostile takeover attempt in the pharmaceutical industry for two years.

Juliana Liu reports from New York.

Go to next video: EU-Asia trade talks in Brussels